AdventHealth: Clinical Trials

5 trials sponsored by AdventHealth, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 21Recruiting 1

Follow AdventHealth: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Suzetrigine for Pain Control Following TKA
Suzetrigine, Placebo - Postoperative Pain Following Knee Arthroplasty
Phase 3Not yet recruitingAdventHealth2102026-03-012026-01-22
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Sotagliflozin, Placebo - Diabetic Nephropathies, Kidney Failure, Chronic
Phase 3RecruitingAlessandro Doria1502024-10-312026-03-24
Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery
Nizaracianine Triflutate, Placebo Comparator - Injury of Ureter During Surgery (Disorder)
Phase 2 / Phase 3RecruitingCuradel Surgical Innovations, Inc.3362024-06-282026-02-23
BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy
BioDFence G3 - Prostate Cancer, Prostatectomy
Phase 3WithdrawnAdventHealth2023-04-012023-06-29
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Cisplatin, Postoperative radiotherapy - Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Phase 3Active not recruitingLisette Nixon12692015-10-012025-02-19

Conditions studied

Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Nephropathies (1)  ·  Heart Failure (1)  ·  Kidney Failure, Chronic (1)  ·  Pain, Postoperative (1)  ·  Prostatic Neoplasms (1)  ·  Urinary Incontinence (1)

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)  ·  Cisplatin (1)  ·  Sugars (1)  ·  ZW800-1 compound (1)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Alessandro Doria, MD PhD MPH (1)  ·  Alexander L Vahrmeijer, M.D., Ph.D (1)  ·  David Cherney, MD PhD (1)  ·  John V Frangioni, M.D., Ph.D. (1)  ·  Mererid Evans, MBBch, PhD (1)  ·  Michael Mauer, MD (1)  ·  Ramakanth Yakkanti, MD (1)  ·  Terrence Jones, MBBS,MD (1)  ·  Vipul R Patel, MD (1)

Results publications

PMID 26311526, PMID 39388196, PMID 39918875